李宇清

发布时间:2025-10-28

姓名:李宇清                                                职称:研究员

办公室:附属华南医院科教楼1302       导师类别:硕导

邮箱:liyuqing@email.szu.edu.cn    办公室电话:0755-21583934


个人简介

李宇清,研究员,博士生导师。深圳大学附属华南医院实验研究部负责人,生物治疗中心副主任,干细胞与转化研究所所长。入选“中国博士后创新人才支持计划”(博新计划)。发表SCI论文30余篇,作为主要作者在Cancer Research和PNAS等杂志发表论文10余篇,获得国家级和省部级项目5项。


主要研究方向

生物多组学大数据分析和提取


代表性成果等

1) Liang M#, Wang Y#, Liu L, Deng D, Yan Z, Feng L, Kong C, Li C, Li Y*, Li G*. Synergistic intravesical instillation for bladder cancer: CRISPR-Cas13a and fenbendazole combination therapy. Journal of Experimental & Clinical Cancer Research. 2024 Aug 12;43(1):223.

2) Zhang L#, Li Y#, Zhou L#, Zhou H, Ye L, Ou T, Hong H, Zheng S, Zhou Z, Wu K, Yan Z, Thiery JP, Cui J, Wu S. The m6A reader YTHDF2 promotes bladder cancer progression by suppressing RIG-I-mediated immune response. Cancer Research. 2023 Jun 2;83(11):1834-1850.

3) Zhou H#, Zhang L#, Luo W, Hong H, Tang D, Zhou D, Zhou L*, Li Y*. AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma. Frontiers in Pharmacology. 2022 Oct 31;13:1050774.

4) Li C#, Li Y#, Li G*, Wu S*. Functional Nanoparticles for Enhanced Cancer Therapy. Pharmaceutics. 2022 Aug 12;14(8):1682.

5) Wang S#, Li Y#, Zhong L#, Wu K, Zhang R, Kang T, Wu S*, Wu Y*. Efficient gene editing through an intronic selection marker in cells. Cellular and Molecular Life Science. 2022 Jan 31;79(2):111.

6) Chen Q#, Chen J#, Li Y#, Liu D, Zeng Y, Tian Z, Yunus A, Yang Y, Lu J, Song X*, Yuan Y*, Kaposi's Sarcoma Herpesvirus is Associated with Osteosarcoma in Xinjiang Populations, the Proceedings of the National Academy of Sciences (PNAS), 2021 Mar 9;118(10):e2016653118.

7) Li Y#, Zhong C#, Liu D, Yu W, Chen W, Wang Y, Shi S, Yuan Y*, Evidence for Kaposi Sarcoma Originating from Mesenchymal Stem Cell through KSHV-induced Mesenchymal-to-Endothelial Transition, Cancer Research, 2018 Jan 1;78(1):230-245.

8) Long X#, Li Y#, Yang M, Huang L, Gong W, Kuang E*, BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-infected Cells by Downregulating Tumor Necrosis Factor Alpha, Journal of Virology, 2016 Aug 12; 90(17): 7880-7893.

9) Li Y, Long X, Huang L, Yang M, Yuan Y, Wang Y, Delecluse HJ, Kuang E*, Epstein-Barr Virus BZLF1-Mediated Downregulation of Proinflammatory Factors is Essential for Optimal Lytic Viral Replication, Journal of Virology, 2015 Nov 4; 90(2): 887-903.


照片

最新动态